339 related articles for article (PubMed ID: 31951754)
1. Use of imaging to assess the activity of hepatic transporters.
Hernández Lozano I; Langer O
Expert Opin Drug Metab Toxicol; 2020 Feb; 16(2):149-164. PubMed ID: 31951754
[No Abstract] [Full Text] [Related]
2. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.
Özvegy-Laczka C; Ungvári O; Bakos É
Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706
[TBL] [Abstract][Full Text] [Related]
3. PET Tracers To Study Clinically Relevant Hepatic Transporters.
Testa A; Zanda M; Elmore CS; Sharma P
Mol Pharm; 2015 Jul; 12(7):2203-16. PubMed ID: 26034841
[TBL] [Abstract][Full Text] [Related]
4. PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.
Mairinger S; Erker T; Muller M; Langer O
Curr Drug Metab; 2011 Oct; 12(8):774-92. PubMed ID: 21434859
[TBL] [Abstract][Full Text] [Related]
5. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance.
Liu X
Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163
[TBL] [Abstract][Full Text] [Related]
6. Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.
Momper JD; Nigam SK
Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):561-570. PubMed ID: 29746174
[TBL] [Abstract][Full Text] [Related]
7. Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter-Enzyme Interplay.
Matsunaga N; Fukuchi Y; Imawaka H; Tamai I
Drug Metab Dispos; 2018 May; 46(5):680-691. PubMed ID: 29352067
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: "SLC-Phenotyping" Using Primary Human Hepatocytes.
Bi YA; Costales C; Mathialagan S; West M; Eatemadpour S; Lazzaro S; Tylaska L; Scialis R; Zhang H; Umland J; Kimoto E; Tess DA; Feng B; Tremaine LM; Varma MVS; Rodrigues AD
J Pharmacol Exp Ther; 2019 Jul; 370(1):72-83. PubMed ID: 30975793
[TBL] [Abstract][Full Text] [Related]
9. Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
Langer O
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S143-56. PubMed ID: 27385172
[TBL] [Abstract][Full Text] [Related]
10. The Structure and Mechanism of Drug Transporters.
Roberts AG
Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696
[TBL] [Abstract][Full Text] [Related]
11. Drug transport proteins in the liver.
Faber KN; Müller M; Jansen PL
Adv Drug Deliv Rev; 2003 Jan; 55(1):107-24. PubMed ID: 12535576
[TBL] [Abstract][Full Text] [Related]
12. Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition.
Ulloa JL; Stahl S; Yates J; Woodhouse N; Kenna JG; Jones HB; Waterton JC; Hockings PD
NMR Biomed; 2013 Oct; 26(10):1258-70. PubMed ID: 23564602
[TBL] [Abstract][Full Text] [Related]
13. Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.
Mayati A; Moreau A; Le Vée M; Stieger B; Denizot C; Parmentier Y; Fardel O
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375174
[TBL] [Abstract][Full Text] [Related]
14. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
15. Circadian regulation of transporter expression and implications for drug disposition.
Pácha J; Balounová K; Soták M
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):425-439. PubMed ID: 33353445
[No Abstract] [Full Text] [Related]
16. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
Mao Q; Lai Y; Wang J
Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
[TBL] [Abstract][Full Text] [Related]
17. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.
Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A
Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621
[TBL] [Abstract][Full Text] [Related]
18. Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition.
Lundquist P; Englund G; Skogastierna C; Lööf J; Johansson J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):448-58. PubMed ID: 24396144
[TBL] [Abstract][Full Text] [Related]
19. Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography.
Hernández Lozano I; Karch R; Bauer M; Blaickner M; Matsuda A; Wulkersdorfer B; Hacker M; Zeitlinger M; Langer O
AAPS J; 2019 Apr; 21(4):61. PubMed ID: 31037511
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of drug-transporter interactions using in vitro and in vivo models.
Xia CQ; Milton MN; Gan LS
Curr Drug Metab; 2007 May; 8(4):341-63. PubMed ID: 17504223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]